Every April, advocates are dedicated to spreading knowledge, promoting acceptance, and creating change for autism. At ViaCord, we like to show our support of Autism Awareness Month by raising awareness about autism and the ongoing research using cord blood and tissue stem cells in clinical trials in an effort to help children with autism.
The Centers for Disease Control recently announced that 1 in 54 kids in the U.S. are diagnosed with autism each year. This incidence rate is up from 1 in 59 kids, making autism awareness more important than ever.Read More
Clinical trials using cord blood in areas of research including autism and cerebral palsy show the potential for it to be a promising option for treatment in the future. Families who have participated in these clinical research trials are thankful to have had the opportunity. But what happens when patients don’t have access to cord blood treatments through clinical trials? That’s where expanded access can help.Read More
What is Hypoplastic Left Heart Syndrome?
Hypoplastic left heart syndrome (HLHS) is a rare, critical birth defect in which the left side of a baby’s heart doesn’t form correctly as it grows during pregnancy. When the left side of the heart is underdeveloped, it restricts normal blood flow to the body and the baby doesn’t get the oxygen within the blood that it needs.Read More
At a time when researchers are just beginning to uncover the full potential of cord blood, it’s so important now more than ever to spread awareness and educate others about the amazing power these stem cells hold. Luckily, World Cord Blood Day was created to do just that! Read More
Riding With Confidence – One Boy’s Story About Participating in Recent Phase II Cerebral Palsy and Cord Blood Clinical Trial
After years of searching for an answer, Patrick’s cerebral palsy diagnosis provided the Rooney family with the definitive answer they had been looking for. Read More
Results of a Phase I Clinical Safety Trial using a child’s own cord blood were recently published, and are giving families and researchers hope. Read More